lung cancer – media

Veracyte, J&J team up on early lung cancer detection

The plan is to create new “interventions" using "field of injury" technology to catch molecular changes in the lining of the respiratory tract, which can indicate cancer or cancer-related changes in the lung.
- Source: https://www.fiercebiotech.com/medtech/veracyte-j-j-team-up-early-lung-cancer-detection
- 2,064
- January 28, 2019
diagnostics genome sequencing Johnson & Johnson lung cancer Veracyte
Two Approvals for AstraZeneca in Japan

The immunotherapy drug was approved for lung cancer patients with no chance for surgery whose cancer had not yet spread to other parts of the body.
- Source: Reuters
- 998
- July 3, 2018
breast cancer Japan lung cancer New Approvals
First-line use of Roche’s Tecentriq given priority review

US regulators are undertaking a priority review of Roche unit Genentech’s PD-L1 inhibitor Tecentriq, in combination with Avastin and standard chemotherapy for some patients with lung cancer.
- Source: pharmatimes
- 628
- May 9, 2018
Chemotherapy lung cancer Roche Tecentriq
OWLSTONE MEDICAL RAISES $15 MILLION USD (£11 MILLION GBP) WITH HORIZONS VENTURES AND AVIVA

SBRI Healthcare alumni and Cambridge-based Owlstone Medical has announced that it has raised $15 million (£11 million) to drive the global commercialisation of its Breath Biopsy® platform.
- Source: eahsn.org
- 531
- March 16, 2018
Breath Biopsy® platform lung cancer Market Views
New AI system for lung cancer and heart disease

Artificial intelligence is gradually being adopted by health services to assist medics with the diagnosis of serious diseases. In one new development, scientists in Oxford, U.K. have launched an AI system for heart disease.
- Source: Digital Journal
- 960
- January 15, 2018
AI heart attacks lung cancer Researches
Encouraging oxygen’s assault on iron may offer new way to kill lung cancer cells

Blocking the motion of a key protein frees oxygen to injury iron-dependent proteins in lung and breast cancer cells, slowing their enlargement and making them more straightforward to kill.
- Source: medical-newspaper
- 558
- November 24, 2017
breast cancer lung cancer Researches
China makes use of AI for healthcare

An estimated 300 million Chinese people are smokers. China has also a serious issue with hazardous air pollution. Here concentrations of small, breathable particles (PM2.5) invariably exceeding 300 micrograms per cubic meter in the industrialized northern regions.
- Source: digitaljournal
- 651
- November 23, 2017
Artificial Intelligence China healthcare lung cancer
AstraZeneca’s Imfinzi gets speedy US review for lung cancer

US regulators have accepted an application by AstraZeneca and MedImmune to expand the scope of Imfinzi (durvalumab) to include patients with a certain form of lung cancer.
- Source: Pharmatimes
- 787
- October 18, 2017
AstraZeneca FDA Imfinzi (durvalumab) lung cancer

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.